About Bohai Pharmaceuticals Group (OTCMKTS:BOPH)
Bohai Pharmaceuticals Group, Inc. is a manufacturer and marketer of herb-based pharmaceutical formulations based on traditional Chinese medicine (TCM). The Company's medicines address rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues and respiratory diseases. The Company produces seven varieties of traditional Chinese herbal medicines in seven delivery systems: tablets, granules, capsules, formulations, concentrated powder, tincture and medicinal wine. The Company's drugs are sold to approximately 2,000 hospitals, 17,000 rural hospitals/clinics and 2,900 retail pharmacies.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Bohai Pharmaceuticals Group (OTCMKTS:BOPH) Frequently Asked Questions
What is Bohai Pharmaceuticals Group's stock symbol?
Bohai Pharmaceuticals Group trades on the OTCMKTS under the ticker symbol "BOPH."
Who are some of Bohai Pharmaceuticals Group's key competitors?
Some companies that are related to Bohai Pharmaceuticals Group include Johnson & Johnson (JNJ), Pfizer (PFE), Novartis (NVS), Merck & Co. (MRK), AbbVie (ABBV), Novo Nordisk (NVO), Abbott Laboratories (ABT), Bayer (BAYRY), Sanofi (SNY), GlaxoSmithKline (GSK), AstraZeneca (AZN), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), Celgene (CELG), Allergan (AGN), Shire (SHPG), Zoetis (ZTS) and Vertex Pharmaceuticals (VRTX).
Who are Bohai Pharmaceuticals Group's key executives?
Bohai Pharmaceuticals Group's management team includes the folowing people:
- Hongwei Qu, Chairman of the Board, President, Chief Executive Officer (Age 37)
- Chunhong Jiang, Treasurer, Secretary (Age 48)
- Thomas Z. Tan, Independent Director (Age 52)
- Chengde Wang, Independent Director (Age 65)
Has Bohai Pharmaceuticals Group been receiving favorable news coverage?
Media stories about BOPH stock have been trending somewhat positive this week, Accern Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bohai Pharmaceuticals Group earned a coverage optimism score of 0.14 on Accern's scale. They also assigned news articles about the company an impact score of 47.59 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Bohai Pharmaceuticals Group?
Shares of BOPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bohai Pharmaceuticals Group's stock price today?
One share of BOPH stock can currently be purchased for approximately $0.0001.
How can I contact Bohai Pharmaceuticals Group?
Bohai Pharmaceuticals Group's mailing address is C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD ZHIFU DISTRICT, YANTAI F4, 264000. The company can be reached via phone at 86-53-5685-7928 or via email at [email protected]
MarketBeat Community Rating for Bohai Pharmaceuticals Group (BOPH)MarketBeat's community ratings are surveys of what our community members think about Bohai Pharmaceuticals Group and other stocks. Vote "Outperform" if you believe BOPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BOPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
Bohai Pharmaceuticals Group (OTCMKTS:BOPH) Analyst Ratings History
(Data available from 4/23/2016 forward)
Bohai Pharmaceuticals Group (OTCMKTS:BOPH) Earnings History and Estimates Chart
Bohai Pharmaceuticals Group (OTCMKTS BOPH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/14/2014||Q1 2015||$0.47||$54.74 million||View||N/A|
|10/14/2014||Q4 2014||$0.17||$45.80 million||View||N/A|
|5/15/2014||Q3 2014||$0.19||$39.72 million||View||N/A|
|2/14/2014||Q2 2014||$0.28||$38.67 million||View||N/A|
|11/14/2013||Q1 2014||$0.38||$50.89 million||View||N/A|
|5/15/2013||Q3 2013||$0.15||$34.79 million||View||N/A|
Bohai Pharmaceuticals Group (OTCMKTS:BOPH) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Bohai Pharmaceuticals Group (OTCMKTS BOPH) Insider Trading and Institutional Ownership History
Bohai Pharmaceuticals Group (OTCMKTS BOPH) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Bohai Pharmaceuticals Group (OTCMKTS BOPH) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Bohai Pharmaceuticals Group (OTCMKTS:BOPH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Bohai Pharmaceuticals Group (OTCMKTS BOPH) Stock Chart for Monday, April, 23, 2018